Search | IOVS | ARVO Journals

Showing 1 – 20 of 82

SORT: Best Match Most Recent Oldest

VIEW: Basic | Expanded

ARVO Annual Meeting Abstract June 2022

Safety and efficacy of fovea-involving half-dose photodynamic therapy for chronic central serous chorioretinopathy

Helena Margaret Anthonia Feenstra; Roselie M.H. Diederen; Martine J.C.M. Lamme; Sascha Fauser; Susan M. Downes; Reinier O. Schlingemann; Carel C B Hoyng; Elon H.C. van Dijk; Camiel J F Boon

Invest. Ophthalmol. Vis. Sci.. 2022; 63(7):37. doi:

ARVO Annual Meeting Abstract June 2022

Sex Hormones in Males and Females with Active Central Serous Chorioretinopathy

Joost Brinks; Elon H.C. van Dijk; Roula Tsonaka; Onno C. Meijer; Camiel J F Boon

Invest. Ophthalmol. Vis. Sci.. 2022; 63(7):1180 – A0034. doi:

ARVO Annual Meeting Abstract June 2022

Clinical and histopathologic characteristics of autosomal dominant cone-rod dystrophy caused by mutations in the CRX gene

Isa van der Veen; Leo Hahn; Michalis Georgiou; Mary J. van Schooneveld; Jacoline B ten Brink; Ralph J. Florijn; Annette Ossewaarde-van Norel; Omar Abdul Rahman Mahroo; Emanuel de Carvalho; Arthur A. Bergen; Michel Michaelides; Camiel J F Boon

Invest. Ophthalmol. Vis. Sci.. 2022; 63(7):1785 – F0334. doi:

ARVO Annual Meeting Abstract June 2022

Generation of an in vitro stem cell based model for researching gyrate atrophy of the choroid and retina

Mark Buijs; Berith Balfoort; Anneloor L M A Ten Asbroek; Camiel J F Boon; Marion Brands; Riekelt Houtkooper; Margreet Wagenmakers; Hans Waterham; Corrie Timmer; Ronald Wanders; Clara Karnebeek; Arthur A. Bergen

Invest. Ophthalmol. Vis. Sci.. 2022; 63(7):2430 – F0374. doi:

ARVO Annual Meeting Abstract June 2022

A comparison of human stem cell-retinal organoid protocols as a way to investigate the timing and regulation of RS1 protein

Andrea Heredero; Philip E Wagstaff; Anneloor L M A Ten Asbroek; Jacoline B ten Brink; Arthur A. Bergen; Camiel J F Boon

Invest. Ophthalmol. Vis. Sci.. 2022; 63(7):2428 – F0372. doi:

ARVO Annual Meeting Abstract June 2022

The evolution and spectrum of structural changes in X-linked retinoschisis on retinal imaging

Leo Hahn; Mary J. van Schooneveld; Ralph J. Florijn; Jacoline B ten Brink; Ine Strubbe; Magda M. Meester-Smoor; Alberta A H J Thiadens; Roselie M.H. Diederen; Caroline C W Klaver; Carel C B Hoyng; Mies M. van Genderen; Bart P Leroy; Arthur A. Bergen; Camiel J F Boon

Invest. Ophthalmol. Vis. Sci.. 2022; 63(7):3319 – F0128. doi:

ARVO Annual Meeting Abstract June 2022

Results of focal photocoagulation in polypoidal choroidal vasculopathy patients from a Dutch referral center

Marc J. Sirks; Helena Margaret Anthonia Feenstra; Florentine R. de Vries; Greet Dijkman; Camiel J F Boon; Elon H.C. van Dijk

Invest. Ophthalmol. Vis. Sci.. 2022; 63(7):3768 – F0189. doi:

ARVO Annual Meeting Abstract June 2022

Spontaneous resolution of subretinal fluid in chronic central serous chorioretinopathy: the Fuji sign

Camiel J F Boon; Helena Margaret Anthonia Feenstra; Jonathan Hensman; Theodora Gkika; Carel C B Hoyng; Roselie M.H. Diederen; Reinier O. Schlingemann; Susan M. Downes; Elon H.C. van Dijk

Invest. Ophthalmol. Vis. Sci.. 2022; 63(7):3763 – F0184. doi:

ARVO Annual Meeting Abstract June 2022

Four-year prospective follow-up in patients with CRB1 -associated retinal dystrophies

Jessica Serena Karuntu; Xuan-Thanh-An Nguyen; Mays Talib; Mary J. van Schooneveld; Jan Wijnholds; Mies M. van Genderen; Nicoline E. Schalij-Delfos; Caroline C W Klaver; Ralph J. Florijn; Jacoline B ten Brink; Magda M. Meester-Smoor; L. Ingeborgh van den Born; Carel C B Hoyng; Alberta A H J Thiadens; Arthur A. Bergen; Camiel J F Boon

Invest. Ophthalmol. Vis. Sci.. 2022; 63(7):4479 – F0266. doi:

ARVO Annual Meeting Abstract June 2022

Reliability of Quantitative Autofluorescence Imaging in a Multicenter Study Involving Patients with Stargardt Disease

Jeroen Adrianus Antonius Hendrikus Pas; Patty P.A. Dhooge; Philipp T. Möller; Katarina Stingl; Camiel J F Boon; Andrew J Lotery; Maurizio Battaglia Parodi; Philipp Herrmann; Wolfgang Klein; Mario G Fsadni; Thomas H. Wheeler-Schilling; Frank G Holz; Carel C B Hoyng; Steffen Schmitz-Valckenberg

Invest. Ophthalmol. Vis. Sci.. 2022; 63(7):4098 – F0062. doi:

ARVO Annual Meeting Abstract June 2022

Efficacy and safety of sepofarsen, an intravitreal RNA antisense oligonucleotide, for the treatment of CEP290 -associated Leber congenital amaurosis (LCA10): a randomized, double-masked, sham-controlled, Phase 3 study (ILLUMINATE)

Bart Peter Leroy; Katarina Stingl; Isabelle S Audo; Camiel J F Boon; Fernanda Belga O Porto; Michel Michaelides; Helene Dollfus; L. Ingeborgh van den Born; Lyubomyr M Lytvynchuk; Francesca Simonelli; Juliana M F Sallum; Robert K Koenekoop; Elise Heon; Stephen R Russell; Michael Schwartz; Aniz Girach

Invest. Ophthalmol. Vis. Sci.. 2022; 63(7):4536 – F0323. doi:

Genetics August 2021

Phenotypic Consequences of the GJD2 Risk Genotype in Myopia Development

PDF

Annechien E. G. Haarman; Clair A. Enthoven; Milly S. Tedja; Jan R. Polling; J. Willem L. Tideman; Jan E. E. Keunen; Camiel J. F. Boon; Janine F. Felix; H. Raat; Annette J. M. Geerards; Gregorius P. M. Luyten; Gwyneth A. van Rijn; Virginie J. M. Verhoeven; Caroline C. W. Klaver
TAGS: adult, genes, genotype, myopia, phenotype, child, refractive errors, biometry
Invest. Ophthalmol. Vis. Sci.. 2021; 62(10):16. doi: https://doi.org/10.1167/iovs.62.10.16

Includes: Supplemental Content

ARVO Annual Meeting Abstract June 2021

Clinical and genetic spectrum of patients with GUCY2D -associated retinal dystrophies

Leo Hahn; Mary J. van Schooneveld; Michalis Georgiou; Magda Meester-Smoor; Andrew J Lotery; Maria M. van Genderen; Jeannette Ossewaarde-van Norel; L. Ingeborgh van den Born; Carel Hoyng; Caroline C. W. Klaver; Susan M Downes; Martin McKibbin; Arthur A.B. Bergen; Bart Leroy; Michel Michaelides; Camiel Boon

Invest. Ophthalmol. Vis. Sci.. 2021; 62(8):1544. doi:

ARVO Annual Meeting Abstract June 2021

A human pluripotent stem cell-derived organ-on-a-chip model of the outer blood-retinal barrier for understanding age-related macular degeneration

Yusuf ARIK; Louet Koolen; Sofie ten Brink; Giuliana Gagliardi; Joost Brinks; Seba Almedawar; Camiel Boon; Peter Benz; Heike Neubauer; Stefan Kauschke; Anneke I Den Hollander; Andries van der Meer

Invest. Ophthalmol. Vis. Sci.. 2021; 62(8):2598. doi:

ARVO Annual Meeting Abstract June 2021

Genome-wide transcriptional responses of human choroidal endothelial cells to corticosteroids as a model for central serous chorioretinopathy

Joost Brinks; Elon van Dijk; Szymon Kielbasa; Hailang Mei; Paul Quax; Onno Meijer; Camiel J F Boon

Invest. Ophthalmol. Vis. Sci.. 2021; 62(8):43. doi:

ARVO Annual Meeting Abstract June 2021

X-linked retinoschisis: Long-term follow-up and genetic spectrum in 340 patients

Camiel J F Boon; Leo Hahn; Mary J. van Schooneveld; Ralph J. Florijn; Jacoline B. ten Brink; Ine Strubbe; Michel H. Hof; Magda Meester-Smoor; Caroline C. W. Klaver; Alberta A. Thiadens; Jeannette Ossewaarde-van Norel; L. Ingeborgh van den Born; Carel Hoyng; Maria M. van Genderen; Bart P Leroy; Arthur A.B. Bergen

Invest. Ophthalmol. Vis. Sci.. 2021; 62(8):2172. doi:

ARVO Annual Meeting Abstract June 2021

Long-term follow-up of chronic central serous chorioretinopathy patients after primary treatment of oral eplerenone or half-dose photodynamic therapy and crossover treatment: SPECTRA trial report No. 3

Helena Feenstra; Thomas Jurian van Rijssen; Roselie Diederen; Carel Hoyng; Reinier Schlingemann; Elon van Dijk; Camiel J F Boon

Invest. Ophthalmol. Vis. Sci.. 2021; 62(8):2170. doi:

ARVO Annual Meeting Abstract June 2021

The impact of the OrCam device on the quality of life in patients with inherited retinal dystrophies

Xuan-Thanh-An Nguyen; Jan Koopman; Maria M. van Genderen; Henk Stam; Camiel J F Boon

Invest. Ophthalmol. Vis. Sci.. 2021; 62(8):3606. doi:

ARVO Annual Meeting Abstract June 2020

Phenotypic consequences of GJD2, the first GWAS hit for common myopia

Annechien Haarman; Clair Enthoven; Jan Keunen; Camiel Boon; Annette Geerards; Gregorius P M Luyten; The Erasmus MC Myopia Research Group Rotterdam; Virginie J.M. Verhoeven; Caroline Klaver

Invest. Ophthalmol. Vis. Sci.. 2020; 61(7):850. doi:

ARVO Annual Meeting Abstract June 2020

A two-year prospective natural history study in patients with CRB1-associated retinal dystrophies: establishing clinical endpoints for future gene therapy trials

Xuan-Thanh-An Nguyen; Mays Talib; Mary J. van Schooneveld; Jan Wijnholds; Maria M. van Genderen; Ralph J. Florijn; Jacoline ten Brink; Frans P Cremers; Magda A. Meester; Caroline Klaver; L. Ingeborgh van den Born; Carel C B Hoyng; Alberta Thiadens; Arthur Bergen; Camiel Boon

Invest. Ophthalmol. Vis. Sci.. 2020; 61(7):3051. doi:

1 2 3 4 5

Next 20 Results »

NARROW

Content Type

Journal

Article Type

Topics

Tags

Specify Date Range

Safety and efficacy of fovea-involving half-dose photodynamic therapy for chronic central serous chorioretinopathy

Sex Hormones in Males and Females with Active Central Serous Chorioretinopathy

Clinical and histopathologic characteristics of autosomal dominant cone-rod dystrophy caused by mutations in the CRX gene

Generation of an in vitro stem cell based model for researching gyrate atrophy of the choroid and retina

A comparison of human stem cell-retinal organoid protocols as a way to investigate the timing and regulation of RS1 protein

The evolution and spectrum of structural changes in X-linked retinoschisis on retinal imaging

Results of focal photocoagulation in polypoidal choroidal vasculopathy patients from a Dutch referral center

Spontaneous resolution of subretinal fluid in chronic central serous chorioretinopathy: the Fuji sign

Four-year prospective follow-up in patients with CRB1 -associated retinal dystrophies

Reliability of Quantitative Autofluorescence Imaging in a Multicenter Study Involving Patients with Stargardt Disease

Efficacy and safety of sepofarsen, an intravitreal RNA antisense oligonucleotide, for the treatment of CEP290 -associated Leber congenital amaurosis (LCA10): a randomized, double-masked, sham-controlled, Phase 3 study (ILLUMINATE)

Phenotypic Consequences of the GJD2 Risk Genotype in Myopia Development

Clinical and genetic spectrum of patients with GUCY2D -associated retinal dystrophies

A human pluripotent stem cell-derived organ-on-a-chip model of the outer blood-retinal barrier for understanding age-related macular degeneration

Genome-wide transcriptional responses of human choroidal endothelial cells to corticosteroids as a model for central serous chorioretinopathy

X-linked retinoschisis: Long-term follow-up and genetic spectrum in 340 patients

Long-term follow-up of chronic central serous chorioretinopathy patients after primary treatment of oral eplerenone or half-dose photodynamic therapy and crossover treatment: SPECTRA trial report No. 3

The impact of the OrCam device on the quality of life in patients with inherited retinal dystrophies

Phenotypic consequences of GJD2, the first GWAS hit for common myopia

A two-year prospective natural history study in patients with CRB1-associated retinal dystrophies: establishing clinical endpoints for future gene therapy trials

To View More...

You must be signed into an individual account to use this feature.